A statewide all-payer claims database would permit more insight into what’s happening with cost and quality of providers, and possibly transform healthcare payment, explained Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition.
A statewide all-payer claims database (APCD) would permit more insight into what’s happening with cost and quality of providers, and possibly transform healthcare payment, explained Karen van Caulil, PhD, president and CEO of the Florida Health Care Coalition.
Transcript (modified)
What is the benefit of a state having an All-Payer Claims Database?
Yeah, I’d really like it to be an all-payer database, not just claims but also quality data, and so that’s sort of a personal mission of mine to expand it beyond APCD to really an all-payer database. But having that information from all of the different self-funded plans, like we have with our large employers but also those who are fully insured and Medicare and Medicaid, and get it all in one place and look at a market level at what’s happening with providers with cost and quality will be very powerful in this move to transform healthcare payment. Without that information, again, we’re very siloed when we’re individual, and having obviously the legislative mandate to do that would be very, very powerful in a short period of time.
Unfortunately, there’s been a Supreme Court ruling [earlier in 2016] that self-funded plans can’t be required to submit their claims. But in Florida our employers who are self-funded understand the importance of that, and I’m encouraged by their reaction to say “we’ll participate, anyway.”
LLMs Show Promise, But Challenges Remain in Improving Inefficient Clinical Trial Screening
July 31st 2025Large language models (LLMs) such as GPT-3.5 and GPT-4 may offer a solution to the costly and inefficient process of manual clinical trial screening, which is often hindered by the inability of structured electronic health record data to capture all necessary criteria.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More